American Association of Nurse Anesthetists

Based in DC

🤖

AI Overview

With $1.7M in lobbying spend across 8 quarterly filings, American Association of Nurse Anesthetists is a significant lobbying presence. They deploy 14 individual lobbyists Their lobbying covers 9 issue areas. Active from 2020 to 2022.

$1.7M
Total Spend
3
Years Active
1
Firms Hired
14
Lobbyists Deployed
9
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$190K
2021$1.3M
2022$220K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Veterans, Insurance, Education and 4 more

Medicare reimbursement and scope of practice issues

HR 1783, Improving Veterans Access to Quality Care Act of 2017

HR 959, Title VIII Nursing Workforce Reauthorization Act of 2017

Chronic Pain management

Rural access to anesthesiologists services act

Nursing Workforce Development

HR 1628, HR 277 The American Health Care Act

Budget Reconciliation Improvement Act

National Defense Authorization Act

Labor Health and Human Services Budget

HR 1783, Improving Veteran Access to Quality Care Act

CRNA Full Practice Authority in the Veterans Health Administration

Provider non discrimination

CRNA reimbursement and coverage issues

Scope of Practice issues

Nursing Workforce Development programs

Appropriate recognition of Certified Registered Nurse Anesthetists

HR 1783, Improving Veterans Access to Quality Care Act

HR 959 Title VIII Reauthorization Act

HR 1628, HR 277, the American Health Care Act

Medicare reimbursement

Chronic Pain management

Nursing workforce development

Reimbursement, Scope of Practice, Full practice authority

Full practice authority, scope of practice issues

Showing 8 of 19 unique descriptions from filings.

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.